Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes

Cancer-related financial hardship (i.e., financial toxicity) has been associated with anxiety and depression, greater pain and symptom burden, treatment nonadherence, and mortality. Out-of-pocket healthcare costs and lost income are primary drivers of financial toxicity, however, income loss is a pr...

Full description

Bibliographic Details
Main Authors: Meredith Doherty, Jonathan Heintz, Amy Leader, David Wittenburg, Yonatan Ben-Shalom, Jessica Jacoby, Amy Castro, Stacia West
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Psychology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1179320/full
_version_ 1827586430591827968
author Meredith Doherty
Jonathan Heintz
Amy Leader
David Wittenburg
Yonatan Ben-Shalom
Jessica Jacoby
Amy Castro
Stacia West
author_facet Meredith Doherty
Jonathan Heintz
Amy Leader
David Wittenburg
Yonatan Ben-Shalom
Jessica Jacoby
Amy Castro
Stacia West
author_sort Meredith Doherty
collection DOAJ
description Cancer-related financial hardship (i.e., financial toxicity) has been associated with anxiety and depression, greater pain and symptom burden, treatment nonadherence, and mortality. Out-of-pocket healthcare costs and lost income are primary drivers of financial toxicity, however, income loss is a pronounced risk factor for cancer patients with low incomes. There has been little progress in developing an income intervention to alleviate financial toxicity cancer patients with low incomes. Unconditional cash transfers (UCT), or guaranteed income, have produced positive health effects in experiments with general low-income populations, but have not yet been evaluated in people with cancer. The Guaranteed Income and Financial Treatment (GIFT) Trial will use a two-arm randomized controlled trial to compare the efficacy of a 12-month UCT intervention providing $1000/month to treatment as usual on financial toxicity, health-related quality of life and treatment adherence in people with cancer who have low-incomes. The study will recruit 250 Medicaid beneficiaries with advanced cancer from two comprehensive cancer centers in Philadelphia, obtain informed consent, and randomize patients to one of two conditions: (1) $1,000/month UCT or (2) treatment as usual. Both arms will receive information on financial toxicity and the contact information for their hospital social worker or financial advocate upon enrollment. Participants will complete online surveys at baseline, 3, 6, 9, and 12 months from enrollment to collect patient-reported data on primary (i.e., financial toxicity, health-related quality of life, and treatment adherence) and secondary outcomes (i.e., anxiety, depression, food insecurity, housing stability). Social security records will be used to explore the effect on mortality at 2, 3, and 5 years post-enrollment. Linear mixed-models will be used to analyze all primary and secondary continuous outcomes over time and general estimating equations with a logit link and binary distribution for all binary outcomes over time. Differences between treatment and control groups and treatment effects will be determined using models that control for age, gender, race, baseline food security, baseline housing stability, and baseline ECOG. Findings from this study will have significant implications for the development and implementation of programs and policies that address the financial burden of cancer and other serious illnesses.
first_indexed 2024-03-09T00:02:14Z
format Article
id doaj.art-9daecab6063a478fbcfc5f672b33bd35
institution Directory Open Access Journal
issn 1664-1078
language English
last_indexed 2024-03-09T00:02:14Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychology
spelling doaj.art-9daecab6063a478fbcfc5f672b33bd352023-12-12T16:59:23ZengFrontiers Media S.A.Frontiers in Psychology1664-10782023-05-011410.3389/fpsyg.2023.11793201179320Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomesMeredith Doherty0Jonathan Heintz1Amy Leader2David Wittenburg3Yonatan Ben-Shalom4Jessica Jacoby5Amy Castro6Stacia West7School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, United StatesSchool of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, United StatesSidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, United StatesMathematica, Princeton, NJ, United StatesMathematica, Princeton, NJ, United StatesSchool of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, United StatesSchool of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, United StatesCollege of Social Work, University of Tennessee, Knoxville, TN, United StatesCancer-related financial hardship (i.e., financial toxicity) has been associated with anxiety and depression, greater pain and symptom burden, treatment nonadherence, and mortality. Out-of-pocket healthcare costs and lost income are primary drivers of financial toxicity, however, income loss is a pronounced risk factor for cancer patients with low incomes. There has been little progress in developing an income intervention to alleviate financial toxicity cancer patients with low incomes. Unconditional cash transfers (UCT), or guaranteed income, have produced positive health effects in experiments with general low-income populations, but have not yet been evaluated in people with cancer. The Guaranteed Income and Financial Treatment (GIFT) Trial will use a two-arm randomized controlled trial to compare the efficacy of a 12-month UCT intervention providing $1000/month to treatment as usual on financial toxicity, health-related quality of life and treatment adherence in people with cancer who have low-incomes. The study will recruit 250 Medicaid beneficiaries with advanced cancer from two comprehensive cancer centers in Philadelphia, obtain informed consent, and randomize patients to one of two conditions: (1) $1,000/month UCT or (2) treatment as usual. Both arms will receive information on financial toxicity and the contact information for their hospital social worker or financial advocate upon enrollment. Participants will complete online surveys at baseline, 3, 6, 9, and 12 months from enrollment to collect patient-reported data on primary (i.e., financial toxicity, health-related quality of life, and treatment adherence) and secondary outcomes (i.e., anxiety, depression, food insecurity, housing stability). Social security records will be used to explore the effect on mortality at 2, 3, and 5 years post-enrollment. Linear mixed-models will be used to analyze all primary and secondary continuous outcomes over time and general estimating equations with a logit link and binary distribution for all binary outcomes over time. Differences between treatment and control groups and treatment effects will be determined using models that control for age, gender, race, baseline food security, baseline housing stability, and baseline ECOG. Findings from this study will have significant implications for the development and implementation of programs and policies that address the financial burden of cancer and other serious illnesses.https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1179320/fullcanceroncologyfinancial toxicityincomeunconditional cash transfersrandomized controlled trial
spellingShingle Meredith Doherty
Jonathan Heintz
Amy Leader
David Wittenburg
Yonatan Ben-Shalom
Jessica Jacoby
Amy Castro
Stacia West
Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes
Frontiers in Psychology
cancer
oncology
financial toxicity
income
unconditional cash transfers
randomized controlled trial
title Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes
title_full Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes
title_fullStr Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes
title_full_unstemmed Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes
title_short Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes
title_sort guaranteed income and financial treatment trial gift trial or giftt a 12 month randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes
topic cancer
oncology
financial toxicity
income
unconditional cash transfers
randomized controlled trial
url https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1179320/full
work_keys_str_mv AT meredithdoherty guaranteedincomeandfinancialtreatmenttrialgifttrialorgiftta12monthrandomizedcontrolledtrialtocomparetheeffectivenessofmonthlyunconditionalcashtransferstotreatmentasusualinreducingfinancialtoxicityinpeoplewithcancerwhohavelowincomes
AT jonathanheintz guaranteedincomeandfinancialtreatmenttrialgifttrialorgiftta12monthrandomizedcontrolledtrialtocomparetheeffectivenessofmonthlyunconditionalcashtransferstotreatmentasusualinreducingfinancialtoxicityinpeoplewithcancerwhohavelowincomes
AT amyleader guaranteedincomeandfinancialtreatmenttrialgifttrialorgiftta12monthrandomizedcontrolledtrialtocomparetheeffectivenessofmonthlyunconditionalcashtransferstotreatmentasusualinreducingfinancialtoxicityinpeoplewithcancerwhohavelowincomes
AT davidwittenburg guaranteedincomeandfinancialtreatmenttrialgifttrialorgiftta12monthrandomizedcontrolledtrialtocomparetheeffectivenessofmonthlyunconditionalcashtransferstotreatmentasusualinreducingfinancialtoxicityinpeoplewithcancerwhohavelowincomes
AT yonatanbenshalom guaranteedincomeandfinancialtreatmenttrialgifttrialorgiftta12monthrandomizedcontrolledtrialtocomparetheeffectivenessofmonthlyunconditionalcashtransferstotreatmentasusualinreducingfinancialtoxicityinpeoplewithcancerwhohavelowincomes
AT jessicajacoby guaranteedincomeandfinancialtreatmenttrialgifttrialorgiftta12monthrandomizedcontrolledtrialtocomparetheeffectivenessofmonthlyunconditionalcashtransferstotreatmentasusualinreducingfinancialtoxicityinpeoplewithcancerwhohavelowincomes
AT amycastro guaranteedincomeandfinancialtreatmenttrialgifttrialorgiftta12monthrandomizedcontrolledtrialtocomparetheeffectivenessofmonthlyunconditionalcashtransferstotreatmentasusualinreducingfinancialtoxicityinpeoplewithcancerwhohavelowincomes
AT staciawest guaranteedincomeandfinancialtreatmenttrialgifttrialorgiftta12monthrandomizedcontrolledtrialtocomparetheeffectivenessofmonthlyunconditionalcashtransferstotreatmentasusualinreducingfinancialtoxicityinpeoplewithcancerwhohavelowincomes